{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:21:12Z","timestamp":1740122472343,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","award":["Ho2016"],"award-info":[{"award-number":["Ho2016"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11239-020-02053-3","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T13:02:42Z","timestamp":1581166962000},"page":"446-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of autoantibodies directed against prothrombin in unprovoked venous thromboembolism"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-183X","authenticated-orcid":false,"given":"Wai Khoon","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rigano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"2053_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bjh.14632","volume":"178","author":"DRJ Arachchillage","year":"2017","unstructured":"Arachchillage DRJ, Laffan M (2017) Pathogenesis and management of antiphospholipid syndrome. Br J Haematol 178:181\u2013195","journal-title":"Br J Haematol"},{"key":"2053_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","volume":"157","author":"D Keeling","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, British Committee for Standards in Haematology (2012) Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47\u201358","journal-title":"Br J Haematol"},{"key":"2053_CR3","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3899\/jrheum.170044","volume":"44","author":"N Zohoury","year":"2017","unstructured":"Zohoury N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, Ateka-Barrutia O, Sorice M, Norman GL, Khamashta M (2017) Closing the serological gap in the antiphospholipid syndrome: the value of \u201cnon-criteria\u201d antiphospholipid antibodies. J Rheumatol 44:1597\u20131602","journal-title":"J Rheumatol"},{"key":"2053_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1160\/TH13-06-0509","volume":"111","author":"S Sciascia","year":"2014","unstructured":"Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML (2014) Anti-prothrombin (aPT) and anti-phosphatidylserine\/prothrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost 111:354\u2013364","journal-title":"Thromb Haemost"},{"key":"2053_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1160\/TH04-06-0382","volume":"93","author":"ML Bertolaccini","year":"2005","unstructured":"Bertolaccini ML, Atsumi T, Koike T, Hughes GRV, Khamashta MA (2005) Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 93:289\u2013297","journal-title":"Thromb Haemost"},{"key":"2053_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1515\/cclm-2017-0502","volume":"56","author":"H Shi","year":"2018","unstructured":"Shi H, Zheng H, Yin YF, Hu QY, Teng JL, Sun Y, Liu HL, Cheng XB, Ye JN, Su YT, Wu XY, Zhou JF, Norman GL, Gong HY, Shi XM, Peng YB, Wang XF, Yang CD (2018) Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Clin Chem Lab Med 56:614\u2013624","journal-title":"Clin Chem Lab Med"},{"key":"2053_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1515\/cclm-2017-0811","volume":"56","author":"S Zhang","year":"2018","unstructured":"Zhang S, Wu Z, Zhang W, Zhao J, Norman GL, Zeng X, Zhang F, Li Y (2018) Antibodies to phosphatidylserine\/prothrombin (aPS\/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome. Clin Chem Lab Med 56:939\u2013946","journal-title":"Clin Chem Lab Med"},{"key":"2053_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1373\/clinchem.2006.073098","volume":"53","author":"L Sabatini","year":"2007","unstructured":"Sabatini L, Torricelli M, Scaccia V, Finsechi D, Pescaglini M, Gasparri L, Florio P, Petraglia F (2007) Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. Clin Chem 53:228\u2013232","journal-title":"Clin Chem"},{"key":"2053_CR9","doi-asserted-by":"publisher","first-page":"975704","DOI":"10.1155\/2015\/975704","volume":"2015","author":"P \u017digon","year":"2015","unstructured":"\u017digon P, Perdan Pirkmajer K, Tom\u0161i\u010d M, Kveder T, Bo\u017ei\u010d B, Sodin \u0160emrl S, \u010cu\u010dnik S, Ambro\u017ei\u010d A (2015) Anti-phosphatidylserine\/prothrombin antibodies are associated with adverse pregnancy outcomes. J Immunol Res 2015:975704. https:\/\/doi.org\/10.1155\/2015\/975704","journal-title":"J Immunol Res"},{"key":"2053_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.20124","volume":"76","author":"K Ishikura","year":"2004","unstructured":"Ishikura K, Wada H, Kamikura Y, Hattori K, Fuzukawa T, Yamada N, Nakamura M, Nobori T, Nakano T (2004) High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 76:338\u2013342","journal-title":"Am J Hematol"},{"key":"2053_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08916930902882731","volume":"42","author":"P Szodoray","year":"2009","unstructured":"Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E (2009) Identification of rare anti-phospholipid\/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity 42:497\u2013506","journal-title":"Autoimmunity"},{"key":"2053_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1076029612437578","volume":"19","author":"A Vlagea","year":"2013","unstructured":"Vlagea A, Gil A, Cuesta MV, Arribas F, Diez J, Lavilla P, Pascual-Salcedo D (2013) Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) as potential markers of antiphospholipid syndrome. Clin Appl Thromb Hemost 19:289\u2013296","journal-title":"Clin Appl Thromb Hemost"},{"key":"2053_CR13","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/rheumatology\/key095","volume":"57","author":"T Marchetti","year":"2018","unstructured":"Marchetti T, Ribi C, Perneger T, Trendelenburg M, Huynh-Do U, de Moerloose P, Chizzolini C (2018) Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus. Rheumatology 57:1350\u20131357","journal-title":"Rheumatology"},{"key":"2053_CR14","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/rheumatology\/kev226","volume":"54","author":"V Rodr\u00edguez-Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez-Garc\u00eda V, Ioannou Y, Fern\u00e1ndez-Nebro A, Isenberg DA, Giles IP (2015) Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. Rheumatology 54:2041\u20132050","journal-title":"Rheumatology"},{"key":"2053_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1515\/cclm-2014-1129","volume":"53","author":"A Hoxha","year":"2015","unstructured":"Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L (2015) Relationship between antiphosphatidylserine\/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Clin Chem Lab Med 53:1265\u20131270","journal-title":"Clin Chem Lab Med"},{"key":"2053_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.thromres.2008.11.003","volume":"124","author":"V Roldan","year":"2009","unstructured":"Roldan V, Lecumberri R, Mu\u00f1oz-Torrero JF, Vicente V, Rocha E, Brenner B, Monreal M, RIETE Investigators (2009) Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res 124:174\u2013177","journal-title":"Thromb Res"},{"key":"2053_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jth.14017","volume":"16","author":"H Cohen","year":"2018","unstructured":"Cohen H, Efthymiou M, Isenberg DA (2018) Use of direct oral anticoagulants in antiphospholipid syndrome. J Thromb Haemost 16:1028\u20131039","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-020-02053-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:42:26Z","timestamp":1612838546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-020-02053-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02053-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"8 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}